Breztri Aerosphere Now Available in the US for Asthma
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
A phase 1 study is testing the safety of a microneedle device designed to deliver peanut protein through the skin for desensitization.
Specific host genotypes and sexes can cause influenza A viruses to gain virulence faster, potentially impacting the severity of flu outbreaks.
A 10-year analysis of emergency department data shows one sport poses a greater risk of severe injury to youth athletes.
New research suggests that excess abdominal fat impairs the lung's immune defenses, allowing non-small cell lung cancer to develop more rapidly.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.